Domestic financing for HIV, TB and malaria in Global Fund High Impact Asia countries
The Global Fund to fight AIDS, Tuberculosis (TB) and malaria is a major financier of these three diseases globally. Since its inception in 2002, the Global Fund has invested more than $41 billion in more than 100 countries. The Global Fund invests the majority of its funds in countries it calls “High Impact countries”. Currently, 24 countries are classified as high impact: 13 countries in sub-Saharan Africa and nine in Asia.1 The Global Fund has also classified one regional grant in Asia as high impact: the Regional Artemisinin-Resistance Initiative 2: Elimination (RAI2E). This grant was first started in 2013 and is in its second phase of implementation, in response to the emergence of drug-resistant malaria in countries in the Greater Mekong region composed of the countries Cambodia, Myanmar, Thailand, Viet Nam, Lao People’s Democratic Republic (PDR) and the Yunnan Province of China. Among those countries and province, the first four are part of high impact Asia.